ArticleScientific reports2025
Global burden of six musculoskeletal disorders in women of childbearing age from 1990 to 2021.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Systematic review of health challenges experienced by Indian women engaged in informal labor.Journal of occupational medicine and toxicology (London, England) · 2026Review
- Article
- Impact of Fiscal Policy for Sugar-Sweetened Beverages on Reducing the Burden of Disease and Healthcare Costs in Brazil: A Simulation Study.Nutrients · 2026Article
- Global Co-Burden and Risk Factors of Low Back Pain and Osteoarthritis: Analysis of Global Burden of Disease 2021 Data Based on Machine Learning and SHAP.Journal of pain research · 2026Article
- Comparative trends in pancreatic cancer burden and risk factors in the USA and China (1990-2021): insights from GBD analysis.BMC gastroenterology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Women of childbearing age (WCBA) are a high-risk group for musculoskeletal (MSK) disorders and face significant challenges. A comprehensive analysis is needed to understand the impacts and develop suitable strategies. Detailed data on MSK disorders in WCBA over the past 32 years, including rheumatoid arthritis (RA), osteoarthritis (OA), low back pain (LBP), neck pain (NP), gout, and other musculoskeletal disorders (OMSKDs), were collected from the Global Burden of Disease database (GBD2021). The burden of these diseases and trends were assessed using prevalence, disability-adjusted life years (DALYs), the Socio-Demographic Index (SDI), and estimated annual percentage changes , with forecasts made up to 2050.From 1990 to 2021, among WCBA, the number of patients with MSK disorders increased from 245,428,271 to 401,422,090. The rate of increase in prevalence was the greatest in middle SDI regions, while high SDI regions bear the highest age-standardized DALYs rate. The conditions with the most significant increase in Age-Standardized Prevalence Rate are ranked as OA, gout, OMSKDs, RA, and NP, while LBP remained relatively unchanged. The ARIMA model forecasts that the number of cases will further rise, and it is estimated that approximately 500 million WCBA will be affected by MSK diseases by 2050. The contributions of obesity and renal dysfunction to the burden of MSK disorders will further increase.WCBA face a significant burden from MSK disorders, and this burden is forecast to increase further. There is an urgent need to invest more in medical resources to manage MSK conditions in WCBA. Focus on the significant increase in specific MSK disorders and controlling modifiable risk factors is crucial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.